These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 15280568

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-TNF-alpha therapy for ankylosing spondylitis--a specific or nonspecific treatment?
    Dayer JM, Krane SM.
    N Engl J Med; 2002 May 02; 346(18):1399-400. PubMed ID: 11986415
    [No Abstract] [Full Text] [Related]

  • 3. The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis.
    Smith N, Gadsby K, Butt S, Deighton C.
    Rheumatology (Oxford); 2007 Jun 02; 46(6):1044-5. PubMed ID: 17401132
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors.
    Her M, Kavanaugh A.
    Curr Opin Rheumatol; 2013 Jul 02; 25(4):455-9. PubMed ID: 23680779
    [Abstract] [Full Text] [Related]

  • 7. Anti-tumour necrosis factor therapy for ankylosing spondylitis--unresolved issues.
    Jois RN, Gaffney K, Keat A.
    Rheumatology (Oxford); 2007 Jun 02; 46(6):899-901. PubMed ID: 17308313
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?
    Gaspersic N, Sersa I, Jevtic V, Tomsic M, Praprotnik S.
    Ann Rheum Dis; 2008 Sep 02; 67(9):1354. PubMed ID: 18697784
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Physical therapy in anti-TNF treated patients with ankylosing spondylitis.
    Dubey SG, Leeder J, Gaffney K.
    Rheumatology (Oxford); 2008 Jul 02; 47(7):1100-1. PubMed ID: 18495822
    [No Abstract] [Full Text] [Related]

  • 15. Adalimumab: new indication. Ankylosing spondylitis: just another TNF alpha antagonist. No comparisons with other TNF alpha antagonists.
    Prescrire Int; 2007 Oct 02; 16(91):193. PubMed ID: 17926830
    [No Abstract] [Full Text] [Related]

  • 16. A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines.
    Temel M, Atagündüz P, Direskeneli H.
    Ann Rheum Dis; 2005 Sep 02; 64(9):1383-4. PubMed ID: 16100352
    [No Abstract] [Full Text] [Related]

  • 17. Do TNF-blockers reduce or induce uveitis?
    Cobo-Ibáñez T, del Carmen Ordóñez M, Muñoz-Fernández S, Madero-Prado R, Martín-Mola E.
    Rheumatology (Oxford); 2008 May 02; 47(5):731-2. PubMed ID: 18346974
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.